The fact that GP's is Pfizer's responsibility came to my mind; but I didn't have the numbers you point out.
Stating they acknowledge "that the current growth trajectory is not as rapid as originally projected. Our goal moving forward is to invest where we can drive continued growth but with an accelerated timeframe to brand profitability" doesn't bode well for HLS.
News 
Market Data 
Discover 
